1. Lebreton F, Willems RJ, Gilmore MS. Enterococcus diversity, origins in nature, and gut colonization. Boston: Massachusetts Eye and Ear Infirmary; 2014.
2. Mohamed JA, Huang DB. Biofilm formation by enterococci. J Med Microbiol. 2007;56(Pt 12):1581-8. pmid: 18033823 doi: 10.1099/jmm.0.47331-0
3. Șchiopu P, Toc DA, Colosi IA, Costache C, Ruospo G, Berar G, et al. An overview of the factors involved in biofilm production by the Enterococcus genus. Int J Mol Sci. 2023;24(14):11577. pmid: 37511337 doi: 10.3390/ijms241411577
4. Procop GW. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 7th ed. Philadelphia: Lippincott William, Wilkins; 2017.
5. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 35th ed. CLSI supplement M100 ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2025.
6. Mirzaei R, Yousefimashouf R, Arabestani MR, Sedighi I, Alikhani MY. The issue beyond resistance: Methicillin-resistant Staphylococcus epidermidis biofilm formation is induced by subinhibitory concentrations of cloxacillin, cefazolin, and clindamycin. PLoS One. 2022;17(11):e0277287. pmid: 36350834 doi: 10.1371/journal.pone.0277287
7. Ghazvinian M, Asgharzadeh Marghmalek S, Gholami M, Amir Gholami S, Amiri E, Goli HR. Antimicrobial resistance patterns, virulence genes, and biofilm formation in enterococci strains collected from different sources. BMC Infect Dis. 2024;24(1):274. pmid: 38438983 doi: 10.1186/s12879-024-09117-2
8. Aladarose BE, Said HS, Abdelmegeed ES. Incidence of virulence determinants among enterococcal clinical isolates in Egypt and its association with biofilm formation. Microb Drug Resist. 2019;25(6):880-9. pmid: 30811265 doi: 10.1089/mdr.2018.0320
9. Fallah F, Yousefi M, Pourmand MR, Hashemi A, Alam AN, Afshar D. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections. Microb Pathog. 2017;108:85-90. pmid: 28483600 doi: 10.1016/j.micpath.2017.05.014
10. Doss Susai backiam A, Duraisamy S, Karuppaiya P, Balakrishnan S, Chandrasekaran B, Kumarasamy A, et al. Antibiotic susceptibility patterns and virulence-associated factors of vancomycin-resistant enterococcal isolates from tertiary care hospitals. Antibiotics (Basel) 2023; 12(6): 981. pmid: 37370300 doi: 10.3390/antibiotics12060981
11. Radford-Smith DE, Anthony DC. Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges. Antibiotics (Basel). 2025;14(5):522. pmid: 40426588 doi: 10.3390/antibiotics14050522
12. Nair P, Sankar S, Neelusree P. Study on Biofilm formation among Enterococcus isolates and Association with their antibiotic resistance patterns. Cureus. 2024;16(2):e53594. pmid: 38449981 doi: 10.7759/cureus.53594
13. Klibi N, Ben Slama K, Sáenz Y, Masmoudi A, Zanetti S, Sechi LA, et al. Detection of virulence factors in high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium isolates from a Tunisian hospital. Can J Microbiol. 2007;53(3):372-9. pmid: 17538646 doi: 10.1139/W06-136
14. Mohamed JA, Murray BE. Lack of correlation of gelatinase production and biofilm formation in a large collection of Enterococcus faecalis isolates. J Clin Microbiol. 2005;43(10):5405-7. pmid: 16208033 doi: 10.1128/JCM.43.10.5405-5407.2005
15. Yang J-x, Liu C-w, Wu F-w, Zhu L, Liang G-w. Molecular characterization and biofilm formation ability of Enterococcus faecium and Enterococcus faecalis bloodstream isolates from a Chinese tertiary hospital in Beijing. Int Microbiol. 2024;27(3):929-39. pmid: 37932582 doi: 10.1007/s10123-023-00441-2
16. Lin P-Y, Chan S-Y, Stern A, Chen P-H, Yang H-C. Epidemiological profiles and pathogenicity of Vancomycin-resistant Enterococcus faecium clinical isolates in Taiwan. PeerJ. 2023;11:e14859. pmid: 36855433 doi: 10.7717/peerj.14859
17. Soltani S, Arshadi M, Getso MI, Aminharati F, Mahmoudi M, Pourmand MR. Prevalence of virulence genes and their association with biofilm formation in VRE faecium isolates from Ahvaz, Iran. J Infect Dev Ctries. 2018;12(11):970-7. pmid: 32012126 doi: 10.3855/jidc.10078
18. Sharma P, Kaur S, Kaur R, Kaur M, Kaur S. Proteinaceous secretory metabolites of probiotic human commensal Enterococcus hirae 20c, E. faecium 12a and L12b as antiproliferative agents against cancer cell lines. Front Microbiol. 2018;9:948. pmid: 29867856 doi: 10.3389/fmicb.2018.00948